Hi all,
a not particularly intensive question here. We recently had a couple of sample identities mixed by our exome sequencing provider (i.e. we got back all our data but some of the .fastq files were misidentified). This is obviously a huge issue.
I was wondering what sort of approaches were taken in other core labs in order to prevent, or at least catch this sort of error? If we're supposedly moving towards clinical sequencing as a standard this really needs not to happen.
Thanks for any suggestions.
a not particularly intensive question here. We recently had a couple of sample identities mixed by our exome sequencing provider (i.e. we got back all our data but some of the .fastq files were misidentified). This is obviously a huge issue.
I was wondering what sort of approaches were taken in other core labs in order to prevent, or at least catch this sort of error? If we're supposedly moving towards clinical sequencing as a standard this really needs not to happen.
Thanks for any suggestions.
Comment